IP Library Granted Patent US 7,824,672
Granted Patent B2
US 7,824,672 · App. 11/091,939 · Granted Nov 2, 2010

Method for coating living cells

Assignee: Emory University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,824,672
App. No.
11/091,939
Granted
Nov 2, 2010
Kind
B2
Abstract

The invention comprises anti-inflammatory conformal barriers with controllable permeability properties that can be applied to living cells prior to transplant, and methods for coating living cells with conformal barriers. The coatings comprise polymer layers deposited on a cell surface by layer-by-layer polymer assembly, wherein each layer contains a positive and a negative polymer pair. The barriers can be actively anti-inflammatory through incorporation of anticoagulant and/or anti-inflammatory agents into the barrier.

Claims (20)

1. A method for coating a living cell surface with a shape-conforming barrier, said method comprising the steps of:

a. providing an isolated living cell having a surface; and

b. conformally coating the cell surface with a shape-conforming barrier layer, wherein the layer comprises a negatively charged polymer and a positively charged polymer so that the charged polymers electrostatically interact within the layer,

wherein there is a plurality of layers, and wherein one layer is an outermost layer and at least one polymer layer comprises photoactive groups for forming interlayer covalent bonds.

2. The method of claim 1 , wherein there is between three or more layers and ten or less layers.

3. The method of claim 1 , further comprising coating the outermost layer with a film selected from the group consisting of a membrane-mimetic film, a charged polymer, and a charged avidin-containing polymer.

4. The method of claim 1 , wherein the negatively charged polymer is alginate.

5. The method of claim 1 , wherein the positively charged polymer is protamine or poly-L-lysine.

6. The method of claim 1 , wherein the barrier further comprises one or more bioactive agents selected from the group consisting of an anticoagulant agent and an anti-inflammatory agent.

7. The method of claim 6 , wherein the bioactive agent is selected from the group consisting of thrombomodulin, heparin and CD39.

8. The method of claim 1 , wherein the living cell is selected from the group consisting of islets, insulin secreting cells, genetically engineered cells designed to secrete bioactive compounds, neurons, cardiac myoblasts, mycocardial cells, chondrocytes, and dopamine secreting cells.

9. A method for coating a living cell surface with a shape-conforming barrier, said method comprising the steps of:

a. providing an isolated living cell having a surface; and

b. conformally coating the cell surface with a shape-conforming barrier layer, wherein the layer comprises a negatively charged polymer and a positively charged polymer so that the charged polymers electrostatically interact within the layer, wherein there is a plurality of layers, wherein one layer is an outermost layer and wherein the polymers within a layer are bound by one or more of electrostatic, covalent, or non-covalent interaction.

10. The method of claim 9 where, the non-covalent interaction is a biotin-streptavidin interaction.

11. The method of claim 9 , wherein there is between three or more layers and ten or less layers.

12. The method of claim 9 , further comprising coating the outermost layer with a film selected from the group consisting of a membrane-mimetic film, a charged polymer, and a charged avidin-containing polymer.

13. The method of claim 9 , wherein the negatively charged polymer is alginate.

14. The method of claim 9 , wherein the positively charged polymer is protamine or poly-L-lysine.

15. The method of claim 9 , wherein the barrier further comprises one or more bioactive agents selected from the group consisting of an anticoagulant agent and an anti-inflammatory agent.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 14, 2011
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025636/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2005
From: CHAIKOF, ELLIOT L.; CUI, WANXING; DAI, ZHIFEI
To: EMORY UNIVERSITY
Reel/Frame 016544/0736 →
Continuity (2)
Provisional Application 6055708800 · Mar 26, 2004
Related Publication 20060002903A1 · Jan 5, 2006